2004 Communication Documentation Pharmaceutical Companies 
ISPE
MAY 9, 2023
In an era when the world is accelerating the development of drugs and targeted medicines using innovative technologies, pharmaceutical companies still face registration hurdles for well-characterized molecules because of redundant or additional local regulatory requirements.
ISPE
MARCH 7, 2023
A collaborative mindset must prevail between pharmaceutical companies, suppliers, and regulators and include strategic partnerships that go beyond the pharmaceutical sector so we can move together to a more sustainable future. The risks are equally applicable to both privately owned and publicly traded companies.
Expert insights. Personalized for you.
52 
Let's personalize your content